Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENOV · against 1,335 other Healthcare companies
Ranked #796 of 1,336 · scores higher than 40% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 40–49, including ENOV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 2.7% | 4.7% | 44% | 33% | |
| Operating marginHigher is better · 1,251 reported | -0.8% | 7.1% | 32% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 1.2% | 1.7% | 46% | 33% | |
| Return on equityHigher is better · 1,252 reported | -54.1% | 3.2% | 14% | Context only | |
| Gross marginHigher is better · 1,394 reported | 61.3% | 45.9% | 68% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 796 | 576M SEK (≈$58M) | 40 | 38 | |
| 796 | 7.2B USD | 40 | 43 | |
| 796 | 23.7B INR (≈$284M) | 40 | 58 | |
| 796 | 12.3B USD | 40 | 35 | |
| 796 | 1.2B USD | 40 | 46 | |
| 796 | 1.1B USD | 40 | 31 | |
| 796 | 5.8B USD | 40 | 38 | |
| 796 | 1.5B EUR (≈$1.6B) | 40 | 44 | |
| 809 | 105.7B KRW (≈$76M) | 39 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score